RAC 0.93% $1.62 race oncology ltd

That's very impressive analysis @Mason14.The implications and...

  1. 919 Posts.
    lightbulb Created with Sketch. 294
    That's very impressive analysis @Mason14.

    The implications and potential of bisantrene is mind boggling. Fast forward say 10 years from now, it will be interesting to know where bisantrene fits in the market, for these metabolic disorders.

    Thanks again.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.